<DOC>
	<DOCNO>NCT02940522</DOCNO>
	<brief_summary>To demonstrate single dose Makena® deliver SQ via auto-injector comparable bioavailability single IM injection Makena® .</brief_summary>
	<brief_title>Comparing Bioavailability When Preservative-free Makena® ( Hydroxyprogesterone Caproate Injection , 250 mg/mL ) Administered Intramuscular Manual Injection Subcutaneous Injection Using Auto-injector Healthy Post-menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>17-alpha-hydroxy-progesterone caproate</mesh_term>
	<mesh_term>11-hydroxyprogesterone</mesh_term>
	<criteria>1 . Naturally surgically postmenopausal woman , without intact uterus , age 50 75 year age , inclusive . FSH level great 40 mIU/mL 1 . Currently take estrogen/progesterone hormone replacement therapy ( HRT ) . 2 . History allergy sensitivity hydroxyprogesterone caproate , castor oil constituent study medication , history drug hypersensitivity intolerance 3 . Poorly control diabetes . 4 . History current evidence deep vein thrombosis , pulmonary embolism arterial thromboembolic disease ( e.g. , stroke , myocardial infarction ) . 5 . Known , suspect , current history carcinoma breast . 6 . Subjects past history breast cancer aromatase inhibitor selective estrogen receptor modulators . 7 . Known , suspect , current history hormone dependent tumor within last 5 year . 8 . Any current recent ( within previous 12 month ) genital bleed unknown etiology . 9 . Receipt investigational drug within 30 day . 10 . Receipt prescription OTC medication know alter CYP3A4 CYP3A5 level ( e.g. , carbamazepine , St. John 's Wort , ketoconazole , rifampin , ritonavir , alprazolam , azithromycin , loratadine , etc . ) within 14 . 11 . Any estrogen , progestin , selective estrogen receptor modulator ( SERM ) treatment within specified time window study start , range 2 6 month . 12 . High blood pressure screen evaluation , define systolic blood pressure &gt; 150 mm Hg diastolic blood pressure &gt; 90 mm Hg . 13 . History excessive alcohol consumption ( average 14 unit alcohol/week ) past 12 month . 14 . Use tobacco product within 30 day start study .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>